Semaglutide
STEP Young
Novo Nordisk · Phase 3 · Active, not recruiting · Enrollment 212
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Group Kids | Obesity or overweight | n/r | n/r | n/r | n/r |
| Group Teens | Obesity or overweight | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Semaglutide
Novo Nordisk · Phase 3 · Active, not recruiting · Enrollment 212
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Group Kids | Obesity or overweight | n/r | n/r | n/r | n/r |
| Group Teens | Obesity or overweight | n/r | n/r | n/r | n/r |